Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Immune Response synthesizes new factor VIII gene

Feb. 23, 2000

Lafon presents piperazinone-based antithrombotic agents

Feb. 22, 2000

AstraZeneca portfolio includes new series of P2T antagonists

Feb. 18, 2000

Stroke news: DuPont gpIIb/IIIa antagonist shows promise in ischemic stroke

Feb. 16, 2000

Anti-gpIIb/IIIa MAb fragment proves effective and safe in rat model of embolic stroke

Feb. 16, 2000

FDA extends decision date for Novastan NDA to Feburary 18

Feb. 15, 2000

UroGen cleared to begin phase I human clinical trial of gene therapy for hemophilia A

Feb. 14, 2000

Sibrafiban no better than aspirin in final analysis of SYMPHONY study

Feb. 11, 2000

German investigators discover new anticoagulant compounds

Feb. 10, 2000

Integrilin stent study halted early due to positive results

Feb. 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...